Understand Congenital Hypertrophy of Retinal Pigment Epithelium (CHRPE), also known as Retinal Pigment Hypertrophy. Learn about CHRPE diagnosis, clinical documentation, and medical coding for healthcare professionals. Find information on CHRPE symptoms, associated conditions, and relevant medical terminology for accurate clinical records and billing. This resource provides essential guidance for documenting and coding CHRPE in healthcare settings.
Also known as
Retinal disorders in diseases classified elsewhere
Covers retinal involvement in other systemic or localized conditions.
Congenital malformations of eye
Includes various congenital eye abnormalities, but specific CHRPE code may not exist.
Chorioretinal inflammations
Although not inflammatory, CHRPE can sometimes mimic inflammatory signs clinically.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the hypertrophy of the retinal pigment epithelium congenital?
Yes
Is it Grouped CHRPE?
No
Do NOT code as CHRPE. Explore acquired causes.
When to use each related code
| Description |
|---|
| Flat, dark spots on the retina. |
| Elevated, dark pigmented lesions on retina. |
| Malignant tumor of the retinal pigment epithelium. |
Missing or incorrect laterality (right, left, bilateral) for CHRPE can impact reimbursement and data accuracy. Proper ICD-10-CM coding with modifiers is crucial for compliance.
Documentation must differentiate between isolated CHRPE and CHRPE associated with Gardner syndrome (familial adenomatous polyposis) for accurate coding (ICD-10 Q12.0 vs. H10.31).
Distinguishing solitary CHRPE from multiple lesions affects coding and potential association with systemic conditions, requiring clear documentation for accurate medical coding and billing.
Q: How can I differentiate Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE) from choroidal melanoma during a funduscopic exam?
A: Differentiating CHRPE from choroidal melanoma is crucial for appropriate management. CHRPE typically presents as a flat, well-circumscribed lesion with a lacunae, or depigmented halo. It often has sharp margins and may demonstrate a characteristic 'bearing tracks' appearance. In contrast, choroidal melanoma tends to be elevated, dome-shaped, and may exhibit orange pigment, subretinal fluid, or overlying drusen. Furthermore, melanoma often grows over time, while CHRPE is generally stable. Ultrasound biomicroscopy (UBM) or optical coherence tomography (OCT) can be used to confirm the diagnosis if there is diagnostic uncertainty. Explore how imaging modalities like UBM and OCT can enhance the diagnostic accuracy in differentiating CHRPE from other suspicious pigmented lesions. Consider implementing a routine follow-up schedule for patients with pigmented lesions to monitor for any changes.
Q: What are the recommended management and follow-up protocols for patients diagnosed with Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE), especially when multiple lesions are present?
A: Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE) is typically benign and requires no intervention for solitary lesions. However, multiple or grouped CHRPE lesions, especially if large and/or demonstrating atypical features like thickening or irregular margins, may raise suspicion for Gardner syndrome, a variant of familial adenomatous polyposis (FAP). In such cases, a thorough systemic evaluation, including a family history and potentially genetic testing for APC gene mutations, is warranted. Consider implementing a comprehensive risk assessment for FAP and genetic counseling for patients with multiple or atypical CHRPE lesions. Learn more about the association between CHRPE and Gardner syndrome to better manage patients with this finding.
Patient presents for ophthalmological evaluation with a suspected Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE). Review of systems includes questions regarding visual acuity, field defects, flashes, floaters, or any family history of CHRPE or Gardner syndrome. Ophthalmoscopic examination reveals a flat, well-demarcated, pigmented lesion consistent with CHRPE. The lesion exhibits characteristic features such as lacunae within the hyperpigmentation and a depigmented halo. Differential diagnosis includes choroidal nevus, melanoma of the choroid, and other retinal pigment epithelial lesions. Given the benign nature of isolated CHRPE findings, management consists of routine ophthalmologic monitoring for any changes in size, shape, or pigmentation. Patient education regarding the natural history of CHRPE and the importance of regular eye exams is provided. ICD-10 code H35.52 (other retinal disorders) is appropriate for billing and coding this condition. Further investigation and genetic counseling may be considered if multiple or bilateral CHRPE lesions are present, raising suspicion for familial adenomatous polyposis (FAP) or Gardner syndrome. Medical decision making is straightforward given the classic clinical presentation.